Abstract:Background: The debate regarding diagnostic classification systems in psychiatry (categorial vs dimensional systems) has essential implications for the diagnosis, prevention and treatment of stress reactions. We previously found a unique pattern of stress reaction in a study executed during the coronavirus disease 2019 pandemic using large representative samples in two countries, and termed it the Complex Stress Reaction Syndrome (CSRS). Aim: To investigate CSRS, Type A (psychiatric symptoms, spanning anxiety, depression, stress symptoms, and post-traumatic stress disorder (PTSD)), with or without long-coronavirus disease (COVID) residuals (CSRS, Type B, neuropsychiatric symptoms spanning cognitive deficits and fatigue, excluding systemic symptoms). Our two-tailed hypothesis was that CSRS is a condition related to an unrecognized type of stress reaction in daily life in the general population (Type A) or that it is related to the severe acute respiratory syndrome coronavirus 2 infection and its long-COVID residuals (Type B). Methods: 977 individuals in four continents (North America, Europe, Australia and the Middle East) completed the online study questionnaire in six languages using the Qualtrics platform. The study was managed by six teams in six countries that promoted the study on social media. The questionnaire assessed anxiety, depression, stress symptoms and PTSD (CSRS, Type A), cognitive deficits and fatigue (CSRS, Type B). The data were analyzed using Proportion Analyses, Multivariate Analysis of Co-Variance (MANCOVA), linear regression analyses and validated clinical cutoff points. Results: The results of the Proportion Analyses showed that the prevalence of 4 symptoms spanning anxiety, depression, stress symptoms, and PTSD was significantly higher than the most prevalent combinations of fewer symptoms across 4 continents, age groups, and gender. This supports the transdiagnostic argument embedded in the CSRS (Type A). The same pattern of results was found in infected/recovered individuals. The prevalence of the 4 psychiatric symptoms combination was significantly greater than that of 5 and 6 symptoms, when adding cognitive deficits and fatigue, respectively. MANCOVA showed a significant three-way interaction (age × gender × continent). Further analyses showed that the sources of this three-way interaction were threefold relating to two sub-populations at-risk: (1) Individuals that self-identified as non-binary gender scored significantly higher on all 4 psychiatric symptoms of the CSRS, Type A at young age groups (< 50 years old) in North America compared to (self-identified) women and men located in the 4 continents studied, and to other ages across the adult life span; and (2) This pattern of results (CSRS, Type A) was found also in women at young ages (< 40 years old) in North America who scored higher compared to men and women in other continents and other ages. Linear regression analyses confirmed the MANCOVA results. Conclusion: These results show a combined mental health risk factor related to stress reactivity, suggesting that the CSRS is sensitive to populations at risk and may be applied to future identification of other vulnerable sub-populations. It also supports the transdiagnostic approach for more accurate prevention and treatment. Time will tell if such transdiagnostic syndromes will be part of the discussions on the next revisions of the traditional classification systems or whether the crisis in psychiatry further evolves.

Is there evidence for factorial invariance of the COVID Stress Scales? an analysis of North American and cross-cultural populations

Measuring psychological response to pandemics: Further psychometric investigation of the COVID Stress Scales

(Don't fear) the factors: An item-level meta-analysis of the fear of COVID-19 Scale's factor structure and measurement invariance

COVID stress syndrome: Concept, structure, and correlates

Cross-cultural Investigation of COVID-19 Related Acute Stress: A Network Analysis.

International study of the Complex Stress Reaction Syndrome: Implications for transdiagnostic clinical practice

The Pandemic Stressor Scale: factorial validity and reliability of a measure of stressors during a pandemic

Subjective Stress Appraisals Over Time: the Evolving Structure of the COVID-19 Stressor Scale

The Fear of COVID-19 Scale: Psychometric properties and measurement invariance across 10 months

Examining the psychometric properties of the CEFIS-AYA using item response theory

Differential effects of COVID-19 stressor types on mental health and moderating roles of coping strategies.

Impact of COVID-19 on college students at one of the most diverse campuses in the USA: a factor analysis of survey data

Co‐rumination and intrapersonal cognitive processes predict distress: Longitudinal evidence from the COVID‐19 pandemic

Development and Evaluation of an Out-of-Control Scale Measuring Global Contextual Stressors Across 20 Countries and Regions

Reliability and Validity of Revised Scale -the Coping Strategies Scale after COVID-19 Based on SPSS 18.0 and AMOS 22.0

Validation of the Cyberchondria Severity Scale (CSS): replication and extension with bifactor modeling

Mental health during the COVID-19 pandemic: Stress and strain profiles in the German population

Three Versions of the Perceived Stress Scale: Psychometric Evaluation in a Nationally Representative Sample of Chinese Adults during the COVID-19 Pandemic

The Development and Validation of a Measure to Assess COVID-19 Stress among College Students for Sustainable Education

Niche diversity influences psychometric properties of a brief personality scale – evidence from representative samples during the COVID-19 pandemic

Factorial Validity, Reliability, Measurement Invariance and the Graded Response Model for the COVID-19 Anxiety Scale in a Sample of Ecuadorians